Regulatory & Legal

Eshallgo Inc. executes a reverse stock split to stay on Nasdaq, but can its AI ambitions overcome deep financial struggles and investor skepticism?

GC Biopharma's new data on ALYGLO's purity profile could set a new standard for IVIG therapies, impacting patient safety in a rapidly growing market.

A new ad campaign attacks hospitals for failing to disclose prices, amplifying a DC battle as HHS Secretary Kennedy faces Congress on healthcare costs.

As Cimpress preps its Q3 results, investors watch to see if record growth can be sustained amid margin pressures in the booming custom print market.

A new ANAB accreditation for OmnexFuturepast aims to bolster trust in vehicle safety and cybersecurity across the entire automotive supply chain.

A new DNA-based method for urine drug testing promises to eliminate invasive observation, boosting accuracy while restoring patient dignity. But is it a true revolution?

A new clinical trial validates the Leva Pelvic Health System, offering a discreet, effective at-home treatment for a condition affecting millions of women.

Inventia Life Science's new RASTRUM Validated Solutions offer standardized 3D models to tackle the reproducibility crisis in pharmaceutical R&D.

Despite major cost cuts and growth in key divisions, DSS, Inc. struggles to convince Wall Street. Can a biotech spin-off finally unlock its true value?

A jury found Live Nation runs an illegal monopoly, but the company vows to fight the verdict. The ruling could reshape the live entertainment landscape.

A new partnership aims to replace endless paperwork with a 'one-tap' app, making elite athlete-led camps more accessible and manageable for families nationwide.

Beztak's entire All Seasons portfolio receives top honors from U.S. News, setting a new benchmark for quality in a booming and competitive market.

After settling a major legal battle, Allied Gaming is ditching its past for an ambitious—and risky—future in AI, tokenization, and a new cryptocurrency.

A new survey shows the Middle East conflict has shattered accountant confidence, pushing geopolitical instability and cyber threats ahead of economic fears.

With a $12B portfolio, real estate giant Lightstone is opening its private playbook to individuals via a new platform with a major co-investment pledge.

A new biotech player is advancing a first-in-class cancer drug that combines two payloads to fight tumors that have become resistant to current therapies.

The strategic acquisition of Axip Energy's assets positions Service Compression as a powerhouse in the booming natural gas compression market.

Facing soaring costs and armed with new laws, America's largest employers are ditching old playbooks to force transparency and value from the healthcare industry.

A new partnership makes a once-weekly malaria pill available online, streamlining travel health for Americans heading to at-risk regions worldwide.

A new FDA-approved powder form of a common blood pressure drug aims to solve a daily struggle for the elderly, children, and tube-fed patients.